Skip to content
CTVACorteva

What Is CTVA Fair Value?

Corteva (CTVA) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, Corteva (CTVA) has a composite fair value estimate of $85.49 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $84.45, suggesting the stock is fair value by 1.2%.

Data as of July 16, 2026 (today)

Composite Fair Value

Fair Value4 of 4 models

$85.49

vs. current price of $84.45(+1.2%)

Undervalued$85.49Overvalued
$84.45

How Is CTVA Fair Value Calculated?

Four independent models estimate what CTVA is worth. Each uses different inputs and assumptions. The composite blends them by weight.

CTVA Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$135.01

+59.9%

Undervalued

Inputs used

FCF: 2.6BGrowth: 11.1%Discount: 7%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$37.64

-55.4%

Overvalued

Inputs used

Dividend: $0.72/yrReq. Return: 8%Growth: 5.5%

CTVA Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$55.39

-34.4%

Overvalued

Inputs used

EPS: $3.75Book Value: $36.36

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$41.63

-50.7%

Overvalued

Inputs used

EPS: $3.75Growth: 11.1%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$135.01Undervalued

Current price $84.45 is 59.9% below this estimate

CheapFair ValueExpensive
11.1%
0.0%30.0%
7.4%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$2.86B$2.67B
Year 2$3.18B$2.76B
Year 3$3.53B$2.85B
Year 4$3.92B$2.95B
Year 5$4.36B$3.06B
Year 6$4.84B$3.16B
Year 7$5.38B$3.27B
Year 8$5.98B$3.39B
Year 9$6.64B$3.50B
Year 10$7.38B$3.63B
Terminal Value$155.47B$76.38B

What Are CTVA's Key Financial Metrics?

Earnings & Growth

Current Price

$84.45

EPS (TTM)

$1.84

Forward P/E

20.5

Profit Margin

6.5%

Cash & Balance Sheet

Free Cash Flow

2.6B

EBITDA

4.1B

Book Value

$36.36

Total Debt

3.4B

What Do Analysts Say About CTVA?

Low

$77.00

Average

$90.20

High

$100.00

Upside

+6.8%

Current $84.45Avg Target $90.20Buy20 analysts

CTVA Fair Value FAQ

What is the fair value of CTVA?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CTVA's estimated fair value is $85.49. The stock is currently trading at $84.45, which makes it fair value by our analysis.

How is CTVA's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is CTVA overvalued or undervalued?

Based on our analysis, CTVA is fair value. The current price of $84.45 is 1.2% below our estimated fair value of $85.49.

What do Wall Street analysts say about CTVA?

20 analysts cover Corteva with a consensus rating of "Buy." The average price target is $90.20, ranging from $77.00 to $100.00. This implies 6.8% upside from the current price.